Inherent Group’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250,000
Closed -$20K 48
2022
Q3
$20K Hold
250,000
﹤0.01% 42
2022
Q2
$24K Hold
250,000
﹤0.01% 29
2022
Q1
$86K Hold
250,000
0.02% 31
2021
Q4
$130K Hold
250,000
0.02% 50
2021
Q3
$145K Buy
+250,000
New +$159K 0.01% 55

Other funds holding EQHA.WS

Inherent Group's EQHA.WS Position: Q4 2022 in Review

Inherent Group sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 250,000 shares — an estimated $20K sold.

Inherent Group first reported a position in EQHA.WS in Q3 2021 and held it in 5 quarters. The position peaked at $145K in Q3 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Inherent Group reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Inherent Group sold 250,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $20K.
  • Inherent Group first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q3 2021 and held it in 5 quarters.
  • Inherent Group's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $145K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Inherent Group's 13F filing for Q4 2022, filed 14 Feb 2023.